FDA recall, , Moderate risk
LifeShare Blood Centers Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced were distributed after incomplete donor eligibility screening.
Recall ended Aug 12, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeShare Blood Centers recalled Apheresis Red Blood Cells, Leukocytes Reduced because the cells were collected from a donor for whom donor eligibility screening was incomplete. The recall began on April 15, 2026, and was classified by the FDA on August 12, 2026. The product was distributed in Louisiana.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeShare Blood Centers
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99420
- Recall number
- B-0183-2026
All recalls from LifeShare Blood Centers
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
